Global Anti-Venom Market Research and Forecast Report 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Anti-Venom Market Research Report: According to the latest report by IMARC Group, titled “ Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-202 7 ,” the global anti-venom market reached a strong growth in 2021. Anti-venom, also known as anti-venin, refers to a purified antibody or medicine that prevents or reverses the snakebite envenoming effects to minimize the risks of paralysis, loss of limb, or even death in patients. It is obtained from the antibodies produced by various animal species, such as snakes, box jellyfish, stonefish, redback and funnel-web spiders. It also helps neutralize the venom to stop it from binding to body tissues, causing severe allergic reactions, blood-clotting, kidney damage, muscle injury, and nervous system problems. Request Free Sample Report: https://www.imarcgroup.com/anti-venom-market/requestsample
Report Description and Highlights Report Description Global Anti-Venom Market Trends : The global anti-venom market is primarily driven by the increasing number of deaths due to venomous bites and stings, especially in rural areas. Additionally, several favorable initiatives undertaken by the governing and non-governing agencies of various countries to spread awareness regarding snakebite envenoming and available treatment options have augmented the product demand. Furthermore, the launch of snake venom detection kits (SVDKs) with a rapid enzyme immunoassay for in vitro detection and immunological identification of snake venom in samples from bite sites, blood, plasma, urine, or other tissues and body fluids has accelerated the product adoption rate. Other factors, including the rising adoption of polyvalent anti-venoms, improving healthcare infrastructure, technological advancements, product innovations, and ongoing research and development (R&D) activities, are also anticipated to catalyze the market growth. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description and Highlights Report Description Market Summary: Breakup by Species: • Snake • Scorpion • Spider • Others Breakup by Anti-venom Type: • Polyvalent Anti-venom • Monovalent Anti-venom Breakup by End User: • Hospitals • Clinics • Ambulatory Surgical Centers
Report Description and Highlights Report Description Breakup by Mode of Action: • Cytotoxic • Neurotoxic • Haemotoxic • Cardiotoxic • Myotoxic • Others
Report Description and Highlights Report Description Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others
Report Description and Highlights Report Description •Latin America • Brazil • Mexico • Others •Middle East and Africa Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • •
Bharat Serums and Vaccines Limited (BSV) Boehringer Ingelheim International GmbH Boston Scientific Corporation CSL Limited Haffkine Bio-Pharmaceutical Corporation Limited Incepta Pharmaceuticals Limited Merck & Co. Inc. Merck KGaA MicroPharm Limited Pfizer Inc. Rare Disease Therapeutics Inc.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/anti-venom-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
We are the trusted business partners to the Partial Listworld's of Clients leading corporates, governments, and institutions
A partial List of our Clients
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com